Kara S, İnci E, Gözen ED, Gülgün KC, Yener HM, et al.
Diving and hyperbaric medicine. Date of publication 2021 Jun 30;volume 51(2):207-209.
1. Diving Hyperb Med. 2021 Jun 30;51(2):207-209. doi: 10.28920/dhm51.2.207-209.
Results of hyperbaric oxygen treatment in an at-risk nasal flap following
trauma.
Kara S(1)(2), İnci E(1), Gözen ED(1)(3), Gülgün KC(4), Yener HM(1)(3).
Author information:
(1)ENT Department, Istanbul University - Cerrahpasa, Istanbul, Turkey.
(2)Corresponding author: Dr Sinem Kara, Istanbul University - Cerrahpasa,
Medical Faculty, ENT Department Cerrahpasa Mh. Kocamustafapasa Cd. No: 53, 34096
Fatih/Istanbul, Turkey, sinemkara25@hotmail.com.
(3)Istanbul University - Cerrahpasa, Istanbul, Turkey.
(4)Oksimer Hyperbaric Oxygen Center, Istanbul, Turkey.
Hyperbaric oxygen treatment (HBOT) is widely used in otorhinolaryngology for
various purposes. A 20-year-old male patient was admitted following a traumatic
nasal wound which occurred several hours prior. He had a nasal glass cut from
the radix to the supratip area which was primarily closed by non-absorbable
suture. The following day, there was a haematoma and necrosis of the skin. The
haematoma was drained under local anaesthesia. Blood supply to the nasal skin
was severely compromised and only the columellar artery remaining intact, by
definition designating this a difficult to heal wound with the risk of overall
healing failure. Necrosis of the skin had developed within the first 24 hours.
Accordingly, the patient underwent 30 HBOT sessions (two hours at 253.3 kPa)
twice daily for four days and daily thereafter. Antibiotic cover and
conservative wound management were also used. Complete healing was achieved
without the need for additional surgical intervention. We conclude that timely
use of HBOT may be a valuable adjunct to conservative wound management in a case
of sharp nasal trauma.
Copyright: This article is the copyright of the authors who grant Diving and
Hyperbaric Medicine a non-exclusive licence to publish the article in electronic
and other forms.
DOI: 10.28920/dhm51.2.207-209
PMCID: PMC8426119
PMID: 34157737 [Indexed for MEDLINE]
Conflict of interest statement: Conflict of interest and funding: nil
